Sorry, we do not have enough data to show an influence graph for this author.
- Full text PDF available (0)
- This year (1)
- Last 5 years (2)
- Last 10 years (2)
Journals and Conferences
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are one of the newer classes of antiglycemic agents approved for the management of patients with type 2 diabetes mellitus. Due to their unique… (More)
PURPOSE OF REVIEW There has been confusion following the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Lipid guidelines on the role of non-statin medications for… (More)